Posts by: Joana Carvalho

Joana Carvalho

Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.

April 1, 2019

Breast Cancer Survivors Weigh in on Ways to Reduce the Financial Burden of the Disease

News

A qualitative study has proposed nine recommendations from breast cancer survivors about how to reduce the financial burden associated with the disease, which include changes to insurance, supportive services, financial ... Read more

March 29, 2019

Frying Oil Reheated Often, Like in Deep Frying, Seen to Promote Breast Cancer’s Spread in Animal Study

News

Frying oil that has repeatedly been reheated to high temperatures — as can take place in deep frying of foods — may cause genetic changes that trigger the growth and ... Read more

March 22, 2019

AI Matches Radiologists’ Skill at Detecting Breast Cancer on Mammograms

News

An artificial intelligence (AI) system based on deep learning algorithms is able to detect breast cancer in digital mammography screenings as well as experienced radiologists, a study says. The findings ... Read more

March 13, 2019

Thousands of Lives Spared Thanks to Screening, Treatment, Study Reports

News

Since 1989, between 384,000 and 615,000 women’s lives have been spared thanks to significant advancements in breast cancer screening methods and treatment, a study reports. The findings of the study, ... Read more

March 8, 2019

FDA Approves Under-the-skin Formulation of Herceptin for Certain Breast Cancers

News

The U.S. Food and Drug Administration (FDA) has approved an under-the-skin formulation of Genentech‘s breast cancer treatment Herceptin (trastuzumab), called Herceptin Hylecta. Also by Genentech, the treatment consists of a combination of trastumuzab and ... Read more

February 25, 2019

More Intense Chemotherapy May Lower Risk of Breast Cancer Recurrence and Death, Study Says

News

Reducing the interval between chemotherapy treatment cycles or administering chemotherapy medications sequentially at higher doses, rather than simultaneously at lower doses, increases treatment efficacy and decreases the risk of breast ... Read more

February 22, 2019

Plerixafor Improves Immunotherapy Response in Mouse Model of Breast Cancer

News

Plerixafor — approved for the treatment of lymphoma and multiple myeloma — decreases tumor fibrosis and improves immunotherapy response in a mouse model of metastatic breast cancer, a study finds. The ... Read more

February 1, 2019

Blocking Interaction Between Blood Vessels, Cancer Cells Could Prevent Disease’s Spread, Study Says

News

Blocking the interaction between cancer cells and their microenvironment could be a viable strategy to eliminate cancer cells that stray from the primary tumor, thereby preventing cancer’s spread, according to ... Read more

January 30, 2019

Mathematical Model Calculates Breast Cancer Risk in Women

News

Researchers developed a mathematical model to calculate breast cancer risk in women, based on family history and genetics. According to investigators, this model not only allows the identification of women ... Read more

January 16, 2019

Breast Cancer Risk Appears to Be Higher in Women Who Have Had Babies, Study Shows

News

Women who have given birth have a higher risk of developing breast cancer, a risk that can persist for more than 20 years after childbirth, compared with women of the ... Read more